CRISPR Stocks List

Related ETFs - A few ETFs which own one or more of the above listed CRISPR stocks.

CRISPR Stocks Recent News

Date Stock Title
Apr 24 CRSP Crispr Therapeutics: Now Is The Time To Buy
Apr 24 CVAC CureVac N.V. 2023 Q4 - Results - Earnings Call Presentation
Apr 24 CVAC CureVac reports Q4 results
Apr 24 CVAC CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Apr 24 CVAC CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Apr 24 CVAC CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
Apr 24 CVAC CureVac to cut costs in restructuring
Apr 23 ABEO Abeona Therapeutics Tanks On CRL From The FDA, But All Hope Is Not Lost
Apr 23 CVAC CureVac BV FQ4 2023 Earnings Preview
Apr 23 ABEO Dow Jumps Over 200 Points; US Services PMI Falls In April
Apr 23 CVAC CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%
Apr 23 ABEO Biggest stock movers today: GM, DHR, IBRX, NVS, and more
Apr 23 ABEO FDA rejects Abeona cell therapy, asks for more manufacturing data
Apr 23 ABEO Calix Reports Mixed Results, Joins Cadence Design Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Apr 22 CRSP CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why
Apr 22 EDIT Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
Apr 22 CRSP CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Apr 22 ABEO FDA requests more info for Abeona pz-cel market application
Apr 22 ABEO Abeona Therapeutics Provides Regulatory Update on Pz-cel
Apr 22 CRSP Cathie Wood’s Latest Stock Portfolio: Top 10 Stock Picks
CRISPR

CRISPR () (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.Cas9 (or "CRISPR-associated 9") is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases..

The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages that provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA. Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.

Browse All Tags